1. Home
  2. TWST

as of 12-22-2025 1:22pm EST

$34.51
+$1.84
+5.62%
Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Chart Type:
Time Range:
Founded: 2013 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 1.6B IPO Year: 2018
Target Price: $44.88 AVG Volume (30 days): 1.3M
Analyst Decision: Buy Number of Analysts: 8
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.30 EPS Growth: N/A
52 Week Low/High: $23.30 - $55.33 Next Earning Date: 02-02-2026
Revenue: $376,572,000 Revenue Growth: 20.32%
Revenue Growth (this year): 15.19% Revenue Growth (next year): 15.10%

AI-Powered TWST Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 19 hours ago

AI Recommendation

hold
Model Accuracy: 82.35%
82.35%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Twist Bioscience Corporation (TWST)

Leproust Emily M.

Chief Executive Officer

Sell
TWST Dec 8, 2025

Avg Cost/Share

$32.88

Shares

2,255

Total Value

$74,139.89

Owned After

875,918

SEC Form 4

Green Paula

SVP of Human Resources

Sell
TWST Dec 8, 2025

Avg Cost/Share

$32.88

Shares

877

Total Value

$28,834.01

Owned After

166,912

SEC Form 4

Cho Dennis

See Remarks

Sell
TWST Dec 8, 2025

Avg Cost/Share

$32.88

Shares

398

Total Value

$13,085.44

Owned After

145,004

SEC Form 4

WERNER ROBERT F.

Chief Accounting Officer

Sell
TWST Dec 8, 2025

Avg Cost/Share

$32.88

Shares

230

Total Value

$7,561.94

Owned After

65,913

SEC Form 4

WERNER ROBERT F.

Chief Accounting Officer

Sell
TWST Nov 24, 2025

Avg Cost/Share

$28.71

Shares

822

Total Value

$23,599.21

Owned After

65,913

SEC Form 4

Leproust Emily M.

Chief Executive Officer

Sell
TWST Nov 21, 2025

Avg Cost/Share

$26.50

Shares

2,663

Total Value

$70,578.82

Owned After

875,918

SEC Form 4

Green Paula

SVP of Human Resources

Sell
TWST Nov 21, 2025

Avg Cost/Share

$26.50

Shares

598

Total Value

$15,849.09

Owned After

166,912

SEC Form 4

Cho Dennis

See Remarks

Sell
TWST Nov 21, 2025

Avg Cost/Share

$26.50

Shares

757

Total Value

$20,063.15

Owned After

145,004

SEC Form 4

WERNER ROBERT F.

Chief Accounting Officer

Sell
TWST Nov 21, 2025

Avg Cost/Share

$26.50

Shares

229

Total Value

$6,069.30

Owned After

65,913

SEC Form 4

Finn Patrick John

President and COO

Sell
TWST Nov 21, 2025

Avg Cost/Share

$26.50

Shares

1,776

Total Value

$47,070.22

Owned After

332,883

SEC Form 4

Latest Twist Bioscience Corporation News

TWST Breaking Stock News: Dive into TWST Ticker-Specific Updates for Smart Investing

All TWST News

Share on Social Networks: